Korean Circ J.  2021 Sep;51(9):792-796. 10.4070/kcj.2021.0202.

Congenital Long QT Syndrome Type 2 with Symptomatic 2:1 Atrioventricular Block and Ventricular Arrhythmia in a Preterm Baby Who Presented with Fetal Ventricular Tachycardia and Hydrops

• Shin JA
• Choi YU
• Kim KM
• Yoon JH
• Lee JY

• KMID: 2519842
• DOI: http://doi.org/10.4070/kcj.2021.0202

Reference

1. Li Y, Fang J, Zhou K, et al. Prediction of fetal outcome without intrauterine intervention using a cardiovascular profile score: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2015; 28:1965–1972. PMID: 25308207.

2. Miyake A, Sakaguchi H, Miyazaki A, Miyoshi T, Aiba T, Shiraishi I. Successful prenatal management of ventricular tachycardia and second-degree atrioventricular block in fetal long QT syndrome. HeartRhythm Case Rep. 2016; 3:53–57. PMID: 28491768.

3. Aziz PF, Tanel RE, Zelster IJ, et al. Congenital long QT syndrome and 2:1 atrioventricular block: an optimistic outcome in the current era. Heart Rhythm. 2010; 7:781–785. PMID: 20197117.

4. Li G, Zhang L. The role of mexiletine in the management of long QT syndrome. J Electrocardiol. 2018; 51:1061–1065. PMID: 30497731.

5. Okuwaki H, Kato Y, Lin L, Nozaki Y, Takahashi-Igari M, Horigome H. Mexiletine infusion challenge test for neonatal long QT syndrome with 2:1 atrioventricular block. J Arrhythm. 2019; 35:685–688. PMID: 31410243.